Search
Showing results for "1"
Research
The advent of recombinant allergens and allergen cloning Authors:When the allergen nomenclature system was adopted in 1986, allergens were identified by their behavior on electrophoresis and chromatography...
Honours/Masters scholarship - now open Applications are open for our Honours / Masters Scholarships with the purpose of providing funding for
News & Events
Technology proves a gamechangerHeidi Bucktin likes to think of her family’s life as pre and post continuous glucose monitoring – that’s how markedly different the two periods are in their journey of living with a child with type 1 diabetes.
Research
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015Globally, life expectancy from birth increased from 61·7 years in 1980 to 71·8 years in 2015
News & Events
Hybrid Closed Loop and Difficult Foods StudyManaging blood glucose levels with different foods can be challenging. Our research team would like to know how the hybrid closed loop system, deals with these foods, compared to standard pump therapy.
Research
Is it still correct to differentiate between early and very early onset psychosis?Larger samples of patients are needed to better understand if the differentiation between very early onset psychosis and early onset psychosis is justified
Research
Cellular and molecular changes to cortical neurons following low intensity repetitive magnetic stimulation at different frequenciesA systematic comparison of the cellular and molecular changes in neurons in vitro induced by low intensity magnetic stimulation at different frequencies.
Research
Gut microbiome and innate immune response patterns in IgE-associated eczemaGut microbiome patterns have been associated with predisposition to eczema potentially through modulation of innate immune signalling.
A world-first study led by Dr Aveni Haynes at The Kids’ Rio Tinto Children’s Diabetes Centre, is helping to detect early changes in blood sugar levels.
Research
Advances in Automated Insulin Delivery with the Medtronic 780G: The Australian ExperienceTo assess the real-world performance of MiniMed™ 780G for Australians with type 1 diabetes (T1D) following advanced hybrid closed loop (AHCL) activation and to evaluate the effect of changing from MiniMed 670/770G to 780G.